FBT Holdings
First Trust NYSE Arca Biotechnology Index Fund
1W: -2.4%
1M: -2.6%
3M: +4.2%
YTD: +28.3%
1Y: +43.7%
3Y: +82.3%
5Y: +55.2%
$266.44
+0.65 (+0.24%)
Weekly Expected Move ±2.7%
$252
$259
$266
$274
$281
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$1.7B
Holdings30
Top 10 Wt39.9%
Beta0.76
% Profitable74%
Coverage100%
Portfolio Valuation
P/E36.9
P/B6.4
P/S6.4
EV/EBITDA25.9
P/FCF23.5
PEG6.82
Profitability & Returns
Gross Margin77.1%
Net Margin13.9%
ROE13.3%
ROA6.4%
ROIC12.6%
Div Yield0.21%
Leverage & Liquidity
Debt/Equity0.71
Debt/Assets0.33
Net Debt/EBITDA1.1x
Interest Cov6.6x
Current Ratio2.26
Quick Ratio1.93
Growth (YoY)
Revenue+24.6%
Net Income+26.3%
EPS+28.0%
FCF+45.8%
EBITDA+17.7%
Rev CAGR 3Y+31.5%
Quality Scores
Piotroski F5.7
Altman Z9.98
IS Quality67.4
IS Overall59.0
IS Value43.0
Median P/E22.6
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 30 | 99.9% | 22.1 |
| Other | 1 | 0.1% | — |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 31 of 31 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Natera, Inc. | NTRA | 4.67% | $138.6M | 335,386 | -301.7 | $58.8B | Healthcare |
| 2 | Halozyme Therapeutics, Inc. | HALO | 4.42% | $131.2M | 1,188,143 | 31.2 | $13.0B | Healthcare |
| 3 | Illumina, Inc. | ILMN | 4.39% | $130.3M | 476,004 | 50.5 | $41.3B | Healthcare |
| 4 | Repligen Corporation | RGEN | 4.07% | $120.7M | 627,681 | 245.5 | $10.3B | Healthcare |
| 5 | NeoGenomics, Inc. | NEO | 3.97% | $117.8M | 6,416,474 | -9.3 | $475M | Healthcare |
| 6 | Corcept Therapeutics Inc. | CORT | 3.83% | $113.5M | 985,377 | 223.5 | $12.6B | Healthcare |
| 7 | Genmab A/S (ADR) | GMAB | 3.75% | $111.4M | 3,121,944 | 26.5 | $21.3B | Healthcare |
| 8 | BeOne Medicines Ltd. (ADR) | ONC | 3.74% | $110.9M | 303,104 | 26.4 | $38.3B | Healthcare |
| 9 | Amgen Inc. | AMGN | 3.54% | $105.0M | 249,143 | 24.8 | $217.5B | Healthcare |
| 10 | Gilead Sciences, Inc. | GILD | 3.50% | $103.9M | 697,344 | -55.7 | $179.5B | Healthcare |
| 11 | Regeneron Pharmaceuticals, Inc. | REGN | 3.48% | $103.3M | 136,243 | 17.6 | $75.7B | Healthcare |
| 12 | Biogen Inc. | BIIB | 3.46% | $102.7M | 454,617 | 38.7 | $32.5B | Healthcare |
| 13 | ADMA Biologics, Inc. | ADMA | 3.37% | $100.0M | 9,970,973 | 13.5 | $2.3B | Healthcare |
| 14 | argenx SE (ADR) | ARGX | 3.33% | $98.9M | 103,163 | 33.3 | $57.2B | Healthcare |
| 15 | Vertex Pharmaceuticals Incorporated | VRTX | 3.29% | $97.5M | 186,520 | 29.1 | $128.1B | Healthcare |
| 16 | Bruker Corporation | BRKR | 3.29% | $97.6M | 1,507,431 | -90.5 | $9.6B | Healthcare |
| 17 | BioNTech SE (ADR) | BNTX | 3.28% | $97.3M | 989,580 | -12.7 | $24.3B | Healthcare |
| 18 | Incyte Corporation | INCY | 3.17% | $94.1M | 775,742 | 14.2 | $23.4B | Healthcare |
| 19 | Exelixis, Inc. | EXEL | 3.15% | $93.6M | 1,602,410 | 17.7 | $14.7B | Healthcare |
| 20 | Bio-Techne Corporation | TECH | 3.10% | $92.0M | 1,269,793 | 61.9 | $11.3B | Healthcare |
| 21 | BioMarin Pharmaceutical Inc. | BMRN | 3.10% | $91.9M | 1,531,399 | 150.5 | $11.1B | Healthcare |
| 22 | United Therapeutics Corporation | UTHR | 3.02% | $89.7M | 165,498 | 17.9 | $23.0B | Healthcare |
| 23 | TG Therapeutics, Inc. | TGTX | 2.98% | $88.4M | 1,585,019 | 17.8 | $8.3B | Healthcare |
| 24 | Sarepta Therapeutics, Inc. | SRPT | 2.93% | $87.0M | 4,777,645 | -12.2 | $1.8B | Healthcare |
| 25 | Madrigal Pharmaceuticals, Inc. | MDGL | 2.86% | $85.0M | 168,689 | -38.7 | $11.5B | Healthcare |
| 26 | Alnylam Pharmaceuticals, Inc. | ALNY | 2.52% | $74.8M | 303,041 | 36.0 | $29.4B | Healthcare |
| 27 | Veracyte, Inc. | VCYT | 2.47% | $73.2M | 1,589,193 | 31.8 | $3.7B | Healthcare |
| 28 | Neurocrine Biosciences, Inc. | NBIX | 2.44% | $72.5M | 511,187 | 20.3 | $14.4B | Healthcare |
| 29 | Axsome Therapeutics, Inc. | AXSM | 2.41% | $71.4M | 387,241 | -47.8 | $9.2B | Healthcare |
| 30 | Alkermes Plc | ALKS | 2.38% | $70.6M | 1,743,095 | 103.6 | $7.0B | Healthcare |
| 31 | US Dollar Private | — | 0.11% | $3.3M | 3,264,807 | — | — | — |